Daily non-political popular news in brief.
Cost control measures limit patient and physician choice in psychotropic medications
03-01-2007 · EurekAlert!A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls. This makes treatment more expensive in many cases for patients, and may affect adherence to treatment, said lead author Dominic Hodgkin, associate professor at the Schneider Institute for Behavioral Health, Heller School for Social Policy and Management at Brandeis University.
Read more »
Keywords: cost, control, measures, limit, patient, physician, choice, psychotropic, medications, measure, medication
« Previous | Next »
Similar news on "Cost control measures limit patient and physician choice in psychotropic medications":
- Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
12-20-2007 · EurekAlert!
The largest study to examine the effect of depression on HIV treatment appears in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The study by Kaiser Permanente and Group Health found depression significantly worsens a patient's adherence to highly active antiretroviral therapy and clinical measures but that effective antidepressant medication reverses this outcome. The study looked at 3,359 HIV-infected patients to measure the effects of depression -- with and without SSRIs.
Similar news · Read more »
- Medication costs infrequently addressed when newly prescribed, UCLA study finds
11-08-2006 · EurekAlert!
A new UCLA study has found that physicians discuss cost and aspects of obtaining newly prescribed medications only about one-third of the time during patient/doctor interactions.But questions about pricing and prescription drug insurance coverage are critical -- the high costs of drugs, including out-of-pocket payouts such as co-payments, are linked to patient non-adherence in maintaining their dosage schedules
Similar news · Read more »
- Older medication may be more cost-effective for some patients with schizophrenia
12-01-2006 · EurekAlert!
A new study analyzing the economic implications of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) concludes that the older (first generation) antipsychotic medication perphenazine was less expensive and no less effective than the newer (second generation) medications used in the trial during initial treatment, suggesting that older antipsychotics still have a role in treating schizophrenia.
Similar news · Read more »
- New cost-benefit model will aid efforts to conserve wilderness: UBC researcher
10-30-2006 · EurekAlert!
A new conservation model that measures the value of ecosystem services benefiting humans -- ranging from flood control to crop pollination -- can foster more win-win solutions between wilderness advocates and landowners, according to University of British Columbia researcher Kai Chan.
Similar news · Read more »
- As dialysis becomes a target of cost control, doctor-patient relationship is key
06-13-2007 · EurekAlert!
As medical, economic, and policy trends converge to alter the way dialysis care is organized and financed, protecting the unique relationship between dialysis patients and the kidney specialists who direct their care is a top priority, according to a special feature in the July Journal of the American Society of Nephrology.
Similar news · Read more »
- Clinical trials for diabetes drugs should measure outcomes important to patients
09-27-2007 · EurekAlert!
Most clinical trials for new diabetes drugs do not consider the impact medication will have on a patient's quality of life or other outcomes that are important to patients, such as the risk of developing complications associated with diabetes, according to a Mayo Clinic commentary in the current issue of the Lancet.
Similar news · Read more »
- Patient-centered approach can backfire
08-13-2007 · EurekAlert!
A University of Iowa study suggests that patients are most satisfied with care and most likely to follow treatment plans -- like taking medication or making diet changes -- if they see a doctor whose attitudes toward patient-physician roles are in line with their own.
Similar news · Read more »
- Patient adherence for successful tuberculosis treatment
03-27-2007 · EurekAlert!
Existing treatment against Tuberculosis is effective but long and many patients abandon it before the end or take their doses at excessively long intervals. In order to improve patients' adherence to treatment, IRD researchers are putting the emphasis on adaptation of control strategies to patients' real geographical, social, health and cultural situation. Trials conducted in Senegal showed the effectiveness of such an approach, which should limit the spread of the disease and the emergence of new resistant strains.
Similar news · Read more »
- Bitter Pill: Costs surge for new schizophrenia drugs
12-09-2006 · Science News Online
Medications widely prescribed to treat schizophrenia cost hundreds of dollars more each month than does a less popular, older medication that has similar success at alleviating symptoms of the disorder.
Similar news · Read more »
- Due to cost, heart attack patients often avoid follow-up care and medication
03-13-2007 · EurekAlert!
A lack of funds to pay for medical treatment and prescriptions is common among heart attack patients and leads to a worse recovery, more angina, poorer quality of life and higher risk of re-hospitalization, according to a study by researchers at Yale School of Medicine. Published in the March 14 issue of Journal of the American Medical Association (JAMA), the study sought to determine if self-reported financial barriers to health care services or medication were associated with worse patient outcomes.
Similar news · Read more »
